DaVita®, the kidney care division of DaVita HealthCare Partners Inc. DVA and a leading provider of kidney care services, today announced an
agreement to provide certain pharmacy services to Fresenius Medical Care
(FMC).
FMC, a leading provider of dialysis services and maker of dialysis products,
will use DaVita Rx® prescription drug services for its Medicare patients in
the United States.
Congress required that beginning in 2011, some oral medications will be
included in the bundled payment model. By 2016 all oral end stage renal
disease medications will be included in the bundled payment. FMC's contract
with DaVita Rx will help implement that requirement by using DaVita Rx's
state-of–the-art pharmacy to fill and ship oral medications to FMC Medicare
patients. DaVita Rx service for FMC will begin in late 2013.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in